Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serial complement measurements in patients with leukaemia.

D Q Minh, E Czink, A Mód

    Clinical and Laboratory Haematology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Detection of Activation Antigens on Chronic Lymphocytic Leukaemia Cells.

    Leukemia & lymphoma·2016
    Same author

    [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].

    Zeitschrift fur Gastroenterologie·2016
    Same author

    OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency.

    Pregnancy hypertension·2015
    Same author

    The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.

    European journal of microbiology & immunology·2014
    Same author

    Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

    Clinical and experimental immunology·2013
    Same author

    Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.

    Genes and immunity·2012

    Complement levels and circulating immune complexes differ across leukemia types. Elevated complement correlates with active acute leukemia and normalizes after chemotherapy, indicating its role in disease progression.

    Area of Science:

    • Immunology
    • Hematology

    Background:

    • The complement system plays a crucial role in immune responses.
    • Leukemia is characterized by abnormal proliferation of blood cells.
    • Alterations in complement pathways and immune complexes may be associated with leukemia.

    Purpose of the Study:

    • To investigate complement system activity and circulating immune complexes in various leukemia types.
    • To correlate complement profiles with clinical status and treatment response in leukemia patients.

    Main Methods:

    • Serial measurement of classical and alternative complement pathway hemolytic activity.
    • Quantification of complement components (C4, C3, Factor B) and circulating immune complexes (CIC).
    • Comparison of complement levels between leukemia patients and healthy controls, and before/after chemotherapy.

    Related Experiment Videos

    Main Results:

    • Distinct complement profiles observed in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL).
    • Elevated complement levels and CIC in AML and ALL, with classical pathway activation in CML.
    • Complement levels normalized post-chemotherapy in acute leukemia, correlating with reduced blast cells.

    Conclusions:

    • Complement system dysregulation is evident in different leukemia subtypes.
    • Elevated complement and CIC are associated with active acute leukemia.
    • Complement levels serve as a potential biomarker for disease activity and treatment response in leukemia.